Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug users.

@article{Grebely2007DirectlyOT,
  title={Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug users.},
  author={Jason Grebely and Jesse D Raffa and Caite Meagher and Fiona Duncan and Krista A Genoway and Milan Khara and Mark B McLean and Annabel Mead and Mark Viljoen and Stanley Devlaming and Chris H Fraser and Brian Conway},
  journal={Journal of gastroenterology and hepatology},
  year={2007},
  volume={22 9},
  pages={1519-25}
}
BACKGROUND AND AIM There are few studies investigating the treatment of hepatitis C virus (HCV) infection in current and former drug users. With this in mind, we sought to evaluate the antiviral efficacy of interferon alpha-2b (IFN alpha-2b) or pegylated-interferon alpha-2b (PEG-IFN alpha-2b) and ribavirin (RBV) in injection drug users (IDU) enrolled in a directly observed therapy (DOT) program, as measured by sustained virologic response (SVR). METHODS Viremic HCV-infected IDU, with alanine… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 36 extracted citations

Similar Papers

Loading similar papers…